Apex, NC, United States of America

Kevin Bugg

This inventor holds 1 USPTO granted patent. Top assignee: Bayer Cropscience Gmbh. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kevin Bugg. Retrieved from https://idiyas.com/inventor/kevin-bugg-7ekhir8f

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Kevin Bugg: Innovator in Pest Control and Plant Health

Introduction

Kevin Bugg is a notable inventor based in Apex, North Carolina. He has made significant contributions to the field of pest control and plant health through his innovative research and development.

Latest Patents

Kevin Bugg holds a patent for "Fusion proteins, recombinant bacteria, and exosporium fragments for pest control and plant health." This invention relates to a fusion protein that includes a targeting sequence, exosporium protein, or exosporium protein fragment. The fusion protein is designed to target the exosporium of a recombinant family member and includes an enzyme with serine protease activity. The patent also describes methods for using these recombinant family members or exosporium fragments for nematode control.

Career Highlights

Kevin Bugg is associated with Bayer CropScience GmbH, where he applies his expertise in biotechnology to develop solutions for agricultural challenges. His work focuses on enhancing plant health and pest management through innovative approaches.

Collaborations

Kevin collaborates with Damian Curtis, leveraging their combined expertise to advance research in pest control and plant health.

Conclusion

Kevin Bugg's contributions to the field of pest control and plant health through his innovative patent demonstrate his commitment to improving agricultural practices. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…